Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. PQ Pharmacy LLC
WARNING LETTER
•PQ Pharmacy LLC•April 4, 2025

PQ Pharmacy LLC – FDA Warning Letter, Apr 4, 2025

Record Details

The FDA issued a Warning Letter to PQ Pharmacy, LLC following an inspection from March 25 to April 4, 2025. The company, registered as an outsourcing facility under Section 503B of the Federal Food, Drug, and Cosmetic Act (FDCA), failed to meet critical conditions for its drug products to qualify for exemptions from certain provisions of the FDCA. Key violations included the omission of established drug names on product labels and inadequate adverse event reporting procedures, specifically regarding the definition of a "serious" adverse event as per 21 CFR 310.305(b). Furthermore, the inspection revealed serious deficiencies in practices for producing sterile drug products, rendering them adulterated under FDCA Section 501(a)(2)(A) due to insanitary conditions. Operators were observed resting arms on work surfaces and disrupting "first air" in aseptic areas, and the firm failed to conduct adequate smoke studies. The company also violated Current Good Manufacturing Practice (CGMP) regulations, leading to adulteration under FDCA Section 501(a)(2)(B). These CGMP failures included inadequate written procedures for production and process control, insufficient procedures to prevent microbiological contamination and validate aseptic processes, a deficient environmental monitoring system, and a failure to thoroughly investigate unexplained discrepancies. PQ Pharmacy, LLC is required to implement comprehensive corrective actions to address these violations and ensure compliance with the FDCA and CGMP regulations to protect public health.

Company
PQ Pharmacy LLC
Inspection date
April 4, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Hale N. Dimetry
  • Frances G. Bormel (Director)
View Company Profile

ID · 95dd53dd-c1c7-4282-bd5e-0669c68edff1

Violation Codes10
21 U.S.C. 351(a)(2)(B)FD&C Act 501(a)(2)(B)FD&C Act 505(a)FD&C Act 301(d)21 U.S.C. 331(k)FD&C Act 301(a)FD&C Act 502(f)(1)FD&C Act 301(k)FD&C Act 501(a)(2)(A)FD&C Act 201(p)

Full citation text and observation details available on the Dashboard.

Other documents for PQ Pharmacy LLC
  • 483 - 2026-06-01June 1, 2026
  • 483 - 2025-04-04April 4, 2025
  • 483 - 2022-10-27October 27, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PQ Pharmacy LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.